Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
28.07
+0.28 (1.01%)
At close: Aug 21, 2026, 4:00 PM EDT
28.08
+0.01 (0.04%)
After-hours: Aug 21, 2026, 7:59 PM EDT

Pfizer Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
9761,1421,0432,8534161,944
Short-Term Investments
10,72312,45419,4349,83722,31629,125
Trading Asset Securities
5----4
Cash & Short-Term Investments
11,70413,59620,47712,69022,73231,073
Cash Growth
-11.66%-33.60%61.36%-44.18%-26.84%153.84%
Accounts Receivable
12,49011,87411,46311,56610,95211,479
Other Receivables
3,7023,9673,3143,9783,5774,266
Receivables
16,19215,84114,77715,54414,52915,745
Inventory
9,94510,65410,85110,1898,9819,059
Other Current Assets
3,5172,8074,2534,9105,0173,816
Total Current Assets
41,35842,89850,35843,33351,25959,693
Property, Plant & Equipment
19,02921,53020,68221,86419,27617,721
Long-Term Investments
1,4601,5272,10815,38214,92621,348
Goodwill
71,41971,26468,52767,78351,37549,208
Other Intangible Assets
47,05353,73155,41164,90043,37025,146
Long-Term Deferred Tax Assets
10,7747,4006,6001,8004,8001,600
Other Long-Term Assets
10,0389,8109,71011,43912,1996,760
Total Assets
201,131208,160213,396226,501197,205181,476

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
4,5815,2405,6336,7106,8095,578
Accrued Expenses
12,61012,26912,0059,2248,3167,671
Short-Term Debt
941573,1968,096385605
Current Portion of Long-Term Debt
2,6143,0133,7782,2702,5701,636
Current Portion of Leases
-330356527620449
Current Income Taxes Payable
6533,1032,9102,3491,5871,266
Current Unearned Revenue
-7841,5112,7002,5203,067
Other Current Liabilities
12,09412,08813,60615,91819,33122,399
Total Current Liabilities
32,64636,98442,99547,79442,13842,671
Long-Term Debt
60,77261,85657,80261,81333,20536,195
Long-Term Leases
-2,2912,2862,6262,5972,510
Pension & Post-Retirement Benefits
1,9372,0412,1152,1672,2503,724
Long-Term Deferred Tax Liabilities
1,9642,4012,1226401,023349
Other Long-Term Liabilities
18,32015,81217,57922,17320,07518,564
Total Liabilities
115,639121,385124,899137,213101,288104,013

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
482481480478476473
Additional Paid-In Capital
95,03394,46993,60392,63191,80290,591
Retained Earnings
112,087114,610116,725118,353125,656103,394
Treasury Stock
-115,194-115,015-114,763-114,487-113,969-111,361
Comprehensive Income & Other
-7,218-8,069-7,842-7,961-8,304-5,896
Total Common Equity
85,19086,47688,20389,01495,66177,201
Minority Interest
302299294274256262
Shareholders' Equity
85,49286,77588,49789,28895,91777,463
Total Liabilities & Equity
201,131208,160213,396226,501197,205181,476

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
63,48067,64767,41875,33239,37741,395
Net Cash (Debt)
-51,776-54,051-46,941-62,642-16,645-10,322
Net Cash Growth
------
Net Cash Per Share
-9.04-9.46-8.24-10.97-2.90-1.81
Filing Date Shares Outstanding
5,7005,6865,6675,6475,6195,623
Total Common Shares Outstanding
5,6995,6865,6675,6465,6165,620
Working Capital
8,7125,9147,363-4,4619,12117,022
Book Value Per Share
14.9515.2115.5615.7717.0313.74
Tangible Book Value
-33,282-38,519-35,735-43,6699162,847
Tangible Book Value Per Share
-5.84-6.77-6.31-7.730.160.51
Land
-299291353368423
Buildings
-9,7449,0369,0468,8329,001
Machinery
-21,85520,61219,66117,37316,710
Construction In Progress
-4,8054,9375,9254,8753,822
SEC Filings: 10-K · 10-Q